China Pharma's Candesartan Hypertension Product Clears Generic Drug Evaluation

The consistency evaluation of generic drugs evaluates approved generic drugs based on the principle that generic drugs need to reach the same level of qual...

August 10, 2023 | Thursday | News
FDA Approves QIAGEN's Companion Diagnostic for AYVAKIT® in Gastrointestinal Stromal Tumors

QIAGEN announced the U.S. Food and Drug Administration (FDA) approval of its therascreen PDGFRA RGQ PCR kit (therascreen PDGFRA kit). This companion diagn...

August 08, 2023 | Tuesday | News
Astellas Invests in Poseida Therapeutics to Redefine Cancer Cell Therapy

Poseida is a clinical-stage biotechnology company dedicated to advancing a new class of cancer cell therapy and gene therapy products using genetic enginee...

August 08, 2023 | Tuesday | News
Within3 Enhances Insights Platform, Cuts Workload by 90%

Within3 announced a major step forward in delivering business impact through artificial intelligence (AI) in the drug commercialization arena. The com...

August 02, 2023 | Wednesday | News
MaxCyte Partners with Prime Medicine to Advance Gene Editing Therapies

MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, de...

August 02, 2023 | Wednesday | News
China's NMPA Accepts Astellas' Zolbetuximab Biologics License Application

Moitreyee Chatterjee-Kishore, PhD, MBA, Senior Vice President and Head of Immuno-Oncology Development, Astellas"China accounts for nearly half of...

August 01, 2023 | Tuesday | News
Melinta Therapeutics Announces Commercial Availability of REZZAYO™ (rezafungin for injection)

Melinta Therapeutics, LLC  announced the availability of REZZAYO™ (rezafungin for injection), for the treatment of candidemia and invasive candi...

August 01, 2023 | Tuesday | News
Amarin and Lotus Pharmaceuticals Partner to Commercialize Vazkepa® in Southeast Asia and South Korea

Amarin Corporation plc (NASDAQ:AMRN) and Lotus Pharmaceuticals (1795:TT; “Lotus”)  announced that the two companies have entered into a lo...

August 01, 2023 | Tuesday | News
Australia: First Patient Dosed in Chemotherapy-Free Soft Tissue Sarcoma Trial.

Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immu...

July 31, 2023 | Monday | News
EmVenio Research & TrialHub Partner to Boost Clinical Trial Efficiency

Through TrialHub's data intelligence gathering platform, EmVenio can easily identify optimal markets to attract clinical trial participants who are needed ...

July 28, 2023 | Friday | News
Everest Medicines Announces Commercial Launch and First Prescription for XERAVA® in China

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization ...

July 27, 2023 | Thursday | News
Bharat Serums and Vaccines Initiates Compliance Measures for Assisted Reproduction Methods

India based biopharmaceutical firm Bharat Serums and Vaccines has roped in Bureau Veritas (India) Pvt. Ltd. (BVIL), a world leader in Audit and Certificati...

July 26, 2023 | Wednesday | News
Lenacapavir Shows Sustained Impact on HIV Patients' Quality of Life

Analyses Show Oral Bridging Maintains Virologic Suppression When Subcutaneous Lenacapavir Doses are Missed – Gilead Sciences, Inc. (Na...

July 26, 2023 | Wednesday | News
IntelGenx Reports Promising Progress in Montelukast VersaFilm® Collaboration for Parkinson's Disease Treatment

IntelGenx Corp. (TSX:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx")  announced the execution of a Research Grant Agreement with Karolinska Unive...

July 26, 2023 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close